Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for REPL

Stock NameReplimune Group Inc
TickerREPL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS76029N1063
LEI549300AY704NEIRC4K64

Show aggregate REPL holdings

News associated with REPL

HC Wainwright Reaffirms “Neutral” Rating for Replimune Group (NASDAQ:REPL)
Replimune Group (NASDAQ:REPL – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. Several other equities analysts have also recently commented on REPL. Barclays cut shares of Replimune Group from an “overweight” rating to an “equal weight” rating and dropped their target […] - 2025-09-10 03:00:56
Stocks Moving Premarket: PMNT, KULR, ENLV, ORGN, And Other Gainers & Losers
(RTTNews) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening bell. - 2025-08-15 08:58:21
Zurcher Kantonalbank Zurich Cantonalbank Purchases 5,876 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 106.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,410 shares of the company’s stock after purchasing an additional 5,876 shares during the period. […] - 2025-08-11 05:32:47
Wednesday's ETF Movers: XBI, OIH
In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.8% on the day. Components of that ETF showing particular strength include shares of Replimune Group, up about 104.8% and shares of Biohaven, up about 18.9% on the day. And underperfor - 2025-07-30 14:51:58
Wednesday Sector Leaders: Music & Electronics Stores, Biotechnology Stocks
In trading on Wednesday, music & electronics stores shares were relative leaders, up on the day by about 5.7%. Leading the group were shares of Global Industrial, up about 21.2% and shares of Vertiv Holdings up about 2.3% on the day. Also showing relative strength are biot - 2025-07-30 14:51:45
Replimune Group, Inc. (NASDAQ:REPL) Receives $21.00 Average PT from Analysts
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twelve brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, two have issued a buy rating and one has given […] - 2025-07-25 05:48:57
Replimune Group (NASDAQ:REPL) Hits New 52-Week Low After Analyst Downgrade
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report)’s stock price hit a new 52-week low on Tuesday after Barclays downgraded the stock from an overweight rating to an equal weight rating. Barclays now has a $3.00 price target on the stock, down from their previous price target of $17.00. Replimune Group traded as low as […] - 2025-07-24 04:24:56
Pre-Market Most Active for Jul 22, 2025 : OPEN, TSLL, REPL, SQQQ, OSCR, NVDA, QS, RXRX, BBAI, JOBY, NIO, CVX
The NASDAQ 100 Pre-Market Indicator is down -5.34 to 23,174.72. The total Pre-Market volume is currently 168,215,532 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.62 at $3.83, with 67,855,698 shares trad - 2025-07-22 09:29:55
Replimune Group (NASDAQ:REPL) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Replimune Group (NASDAQ:REPL – Get Free Report) had its target price increased by research analysts at JPMorgan Chase & Co. from $16.00 to $19.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 52.00% […] - 2025-07-18 05:05:13
Replimune Group (NASDAQ:REPL) Shares Gap Up Following Analyst Upgrade
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report)’s stock price gapped up before the market opened on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $16.00 to $19.00. The stock had previously closed at $12.40, but opened at $13.19. JPMorgan Chase & Co. currently has an overweight rating on […] - 2025-07-18 02:20:52
LABU's Holdings Imply 58% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-10 07:59:01
Exchange Traded Concepts LLC Sells 5,196 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Exchange Traded Concepts LLC trimmed its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 32.5% in the first quarter, HoldingsChannel.com reports. The firm owned 10,814 shares of the company’s stock after selling 5,196 shares during the period. Exchange Traded Concepts LLC’s holdings in Replimune Group were worth $105,000 at the end of the […] - 2025-06-25 04:57:01
California State Teachers Retirement System Raises Stake in Replimune Group, Inc. (NASDAQ:REPL)
California State Teachers Retirement System boosted its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 25.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 42,725 shares of the company’s stock after purchasing an additional 8,793 shares during the period. California State Teachers Retirement System’s holdings in Replimune Group were worth […] - 2025-06-12 04:52:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $796,000 Stake in Replimune Group, Inc. (NASDAQ:REPL)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 19.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,762 shares of the company’s stock after selling 15,402 […] - 2025-06-11 04:38:55
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Consensus PT from Analysts
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has earned an average rating of “Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price […] - 2025-06-03 03:07:12
Two Sigma Investments LP Buys 33,346 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Two Sigma Investments LP boosted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 212,586 shares of the company’s stock after acquiring an additional 33,346 shares during […] - 2025-06-01 06:37:00
Replimune Group, Inc. (NASDAQ:REPL) Stock Position Lifted by ProShare Advisors LLC
ProShare Advisors LLC grew its position in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 33.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,788 shares of the company’s stock after buying an additional 5,247 shares during the […] - 2025-06-01 05:46:47
Thursday's ETF Movers: XBI, URA
In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Oric Pharmaceuticals, up about 33.8% and shares of Replimune Group, up about 9.6% on the day. And un - 2025-05-29 12:59:01
Two Sigma Advisers LP Lowers Position in Replimune Group, Inc. (NASDAQ:REPL)
Two Sigma Advisers LP decreased its position in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 9.6% during the fourth quarter, Holdings Channel reports. The fund owned 170,400 shares of the company’s stock after selling 18,000 shares during the period. Two Sigma Advisers LP’s holdings in Replimune Group were worth $2,064,000 as of […] - 2025-05-29 05:52:49
Nuveen Asset Management LLC Boosts Stake in Replimune Group, Inc. (NASDAQ:REPL)
Nuveen Asset Management LLC lifted its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 108.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 667,634 shares of the company’s stock after purchasing an additional 347,993 shares during the period. Nuveen Asset […] - 2025-05-29 04:56:55
Quantinno Capital Management LP Invests $127,000 in Replimune Group, Inc. (NASDAQ:REPL)
Quantinno Capital Management LP acquired a new stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 10,455 shares of the company’s stock, valued at approximately $127,000. Other institutional investors and […] - 2025-05-28 05:08:55
Investors Buy High Volume of Replimune Group Call Options (NASDAQ:REPL)
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) saw some unusual options trading on Thursday. Traders acquired 5,508 call options on the stock. This is an increase of approximately 652% compared to the average volume of 732 call options. Insider Buying and Selling at Replimune Group In other Replimune Group news, CAO Andrew Schwendenman sold […] - 2025-05-23 02:01:01
Hsbc Holdings PLC Buys Shares of 14,008 Replimune Group, Inc. (NASDAQ:REPL)
Hsbc Holdings PLC purchased a new position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 14,008 shares of the company’s stock, valued at approximately $175,000. Several other hedge funds also recently modified their holdings of the business. Sterling Capital Management LLC increased its position in Replimune […] - 2025-05-12 04:56:47
Barclays PLC Raises Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)
Barclays PLC boosted its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 167,329 shares of the company’s stock after acquiring an additional 8,838 shares during the quarter. […] - 2025-05-02 06:03:01
Invesco Ltd. Trims Stock Position in Replimune Group, Inc. (NASDAQ:REPL)
Invesco Ltd. cut its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 51.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 88,006 shares of the company’s stock after selling 92,952 shares during the period. Invesco Ltd.’s holdings in Replimune Group were worth $1,066,000 […] - 2025-05-02 04:30:49
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Wells Fargo & Company MN
Wells Fargo & Company MN boosted its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 102.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 77,371 shares of the company’s stock after acquiring an additional 39,121 shares during the period. Wells Fargo & Company MN’s holdings in Replimune Group were worth $937,000 as […] - 2025-04-30 05:14:51
Legal & General Group Plc Acquires 17,597 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Legal & General Group Plc lifted its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 42.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,366 shares of the company’s stock after purchasing an additional 17,597 shares during the […] - 2025-04-29 04:50:50
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $19.43
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target […] - 2025-04-14 02:59:04
Corebridge Financial Inc. Sells 2,284 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Corebridge Financial Inc. trimmed its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 7.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 30,267 shares of the company’s stock after selling 2,284 shares during the period. Corebridge Financial Inc.’s holdings in Replimune Group were worth $367,000 at the end of the most […] - 2025-04-10 05:33:06

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc REPL holdings

DateNumber of REPL Shares HeldBase Market Value of REPL SharesLocal Market Value of REPL SharesChange in REPL Shares HeldChange in REPL Base ValueCurrent Price per REPL Share HeldPrevious Price per REPL Share Held
2025-10-16 (Thursday)10,511USD 49,086USD 49,086
2025-10-15 (Wednesday)10,511USD 49,822USD 49,822
2025-10-13 (Monday)10,319USD 47,055USD 47,055
2025-10-09 (Thursday)10,319USD 47,777USD 47,777
2025-10-07 (Tuesday)10,319USD 47,983USD 47,983
2025-10-06 (Monday)10,287USD 48,143USD 48,143
2025-10-03 (Friday)10,287USD 48,658REPL holding increased by 823USD 48,6580USD 823 USD 4.73005 USD 4.65004
2025-10-02 (Thursday)10,287REPL holding increased by 32USD 47,835REPL holding increased by 4661USD 47,83532USD 4,661 USD 4.65004 USD 4.21004
2025-10-01 (Wednesday)10,255USD 43,174REPL holding increased by 206USD 43,1740USD 206 USD 4.21004 USD 4.18996
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REPL by Blackrock for IE00B3VWM098

Show aggregate share trades of REPL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-02BUY32 4.650* 10.42
2025-09-30BUY64 4.190* 10.49
2025-08-21SELL-32 5.600* 10.66 Profit of 341 on sale
2025-07-31BUY96 7.030* 10.72
2025-06-30SELL-64 9.290* 10.95 Profit of 701 on sale
2025-06-25SELL-32 9.450* 10.98 Profit of 351 on sale
2025-06-20SELL-64 9.270* 11.02 Profit of 705 on sale
2025-05-23BUY32 8.350* 11.27
2025-05-19SELL-32 8.200* 11.36 Profit of 364 on sale
2025-05-15SELL-96 7.230* 11.43 Profit of 1,097 on sale
2025-05-12SELL-32 7.860* 11.54 Profit of 369 on sale
2025-05-09SELL-32 7.710* 11.57 Profit of 370 on sale
2025-04-30SELL-32 9.780* 11.76 Profit of 376 on sale
2025-04-24SELL-64 9.060* 11.86 Profit of 759 on sale
2025-04-17SELL-32 7.995* 12.04 Profit of 385 on sale
2025-04-15SELL-96 7.710* 12.13 Profit of 1,165 on sale
2025-04-14SELL-96 7.510* 12.18 Profit of 1,169 on sale
2025-04-09SELL-128 7.310* 12.35 Profit of 1,581 on sale
2025-04-07SELL-224 7.490* 12.47 Profit of 2,792 on sale
2025-04-04SELL-320 7.460* 12.52 Profit of 4,008 on sale
2025-03-31BUY32 9.750* 12.65
2025-03-19SELL-64 11.500* 12.85 Profit of 822 on sale
2025-03-14SELL-192 11.655* 12.90 Profit of 2,476 on sale
2025-03-13SELL-64 11.860* 12.91 Profit of 826 on sale
2025-03-12SELL-1,088 12.110* 12.92 Profit of 14,059 on sale
2025-03-07SELL-64 11.510* 12.99 Profit of 831 on sale
2025-03-06SELL-96 11.740* 13.01 Profit of 1,249 on sale
2025-03-03SELL-32 12.120* 13.05 Profit of 418 on sale
2025-02-28SELL-21,630 12.680* 13.06 Profit of 282,448 on sale
2025-02-26SELL-89 13.240* 13.06 Profit of 1,163 on sale
2025-02-25SELL-267 13.490* 13.05 Profit of 3,486 on sale
2025-02-18BUY445 14.030* 12.96
2025-02-13BUY89 14.290* 12.89
2025-02-12BUY89 13.790* 12.87
2025-02-11BUY267 12.850* 12.87
2025-02-06BUY801 14.060* 12.81
2025-01-27BUY89 13.690* 12.57
2024-12-30BUY445 12.330* 12.51
2024-12-06BUY356 13.080* 12.48
2024-12-05BUY89 13.050* 12.46
2024-12-04BUY445 13.170* 12.43
2024-11-29BUY445 14.080* 12.29
2024-11-27BUY356 14.050* 12.14
2024-11-26BUY89 14.380* 12.04
2024-11-25BUY10,331 13.260* 11.98
2024-11-21BUY290 11.050* 11.88
2024-11-20BUY174 11.230* 11.91
2024-11-18BUY686 10.770* 12.04
2024-11-12BUY456 12.190* 12.03
2024-11-08BUY285 12.440* 12.01
2024-11-07BUY855 12.210* 11.99
2024-11-06BUY114 12.700* 11.93
2024-10-31BUY57 11.760* 11.93
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REPL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,155,27179,7803,328,20434.7%
2025-09-186,516,587175,10616,426,64339.7%
2025-09-17368,5105,734873,88042.2%
2025-09-16416,99301,186,29135.2%
2025-09-15306,66319,9161,348,60222.7%
2025-09-12159,691377627,15225.5%
2025-09-11310,480562940,45033.0%
2025-09-10228,4633,406839,42627.2%
2025-09-09207,4070677,81930.6%
2025-09-08192,0411001,439,09913.3%
2025-09-05236,05601,545,92615.3%
2025-09-04429,3662,400891,49048.2%
2025-09-03286,9240947,24230.3%
2025-09-02481,1134721,709,09428.2%
2025-08-29221,7946731,79430.3%
2025-08-28195,2805,032457,35342.7%
2025-08-27168,3460383,24343.9%
2025-08-26144,3591,157405,92135.6%
2025-08-25211,8010572,40037.0%
2025-08-22399,8620984,91040.6%
2025-08-21460,1502,7321,311,40735.1%
2025-08-20231,2342,167622,09037.2%
2025-08-19258,32410,646706,87136.5%
2025-08-18405,40925,4901,156,11035.1%
2025-08-15949,09812,216,16642.8%
2025-08-14384,9517311,393,00327.6%
2025-08-13538,87301,384,60138.9%
2025-08-12303,24531,5051,531,27919.8%
2025-08-11562,23916,0972,419,84623.2%
2025-08-081,116,75411,987,84356.2%
2025-08-07653,63850,0922,515,40026.0%
2025-08-061,249,4339,2613,550,15235.2%
2025-08-051,163,52026,4103,477,26433.5%
2025-08-042,738,143249,4088,569,06632.0%
2025-08-011,847,429151,1284,123,42744.8%
2025-07-313,517,615319,0819,025,98739.0%
2025-07-3035,205,916228,53484,188,53841.8%
2025-07-297,579,23222,62215,076,44350.3%
2025-07-28923,3691123,198,84628.9%
2025-07-25708,6528,0032,864,43024.7%
2025-07-241,532,1728,4576,415,57623.9%
2025-07-236,581,948689,13623,556,73427.9%
2025-07-2224,781,0222,885,92137,903,81365.4%
2025-07-211,187,8151,6001,778,06866.8%
2025-07-18689,488911,366,95150.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.